Alpha 2.0
Login Register
» Articles » PMID: 4587143

Immunopotentiation with BCG. IV. Factors Affecting the Magnitude of an Antitumor Response

Overview
Journal J Natl Cancer Inst
Publisher Oxford University Press
Specialty Oncology
Date 1973 Nov 1
PMID 4587143
Citations 4
Authors
E HAWRYLKO
G B Mackaness
Affiliations
Soon will be listed here.
Citing Articles

Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.

De Jong W, Steerenberg P, Kreeftenberg J, Tiesjema R, Kruizinga W, VAN NOORLE JANSEN L Cancer Immunol Immunother. 1984; 17(1):18-27.

PMID: 6563941 PMC: 11039122. DOI: 10.1007/BF00205492.

Modulation of antitumor immunity--immunobiologic approaches.

NORTH R, Dye E, Mills C, CHANDLER J Springer Semin Immunopathol. 1982; 5(2):193-220.

PMID: 6293113 DOI: 10.1007/BF00199796.

Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

Juy D, CHEDID L Proc Natl Acad Sci U S A. 1975; 72(10):4105-9.

PMID: 812088 PMC: 433147. DOI: 10.1073/pnas.72.10.4105.

Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Schwarz M, Gutterman J, Hersh E, Richman S, Mavligit G World J Surg. 1977; 1(5):555-83.

PMID: 272083 DOI: 10.1007/BF01556181.